gallium nitrate: Clinical Trials

3 trials of gallium nitrate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Withdrawn 1

Follow gallium nitrate: new trials by email Literature Review of gallium nitrate trials Research Report on gallium nitrate

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gan & Lee Evaluation of New Biosimilar for Type 1 Lispro
Gan & Lee Insulin Lispro Injection, Humalog - Diabetes Mellitus, Type 1
Phase 3WithdrawnGan and Lee Pharmaceuticals, USA2019-12-042020-02-05
Gan & Lee Insulin Glargine Target Type (2) Evaluating Research
Gan & Lee Insulin Glargine Injection, LantusĀ® - Diabetes Mellitus, Type 2
Phase 3CompletedGan and Lee Pharmaceuticals, USA5672017-10-312022-04-01
Gan & Lee Insulin Glargine Target Type (1) Evaluating Research
Gan & Lee Insulin Glargine Injection, LantusĀ® - Diabetes Mellitus, Type 1
Phase 3CompletedGan and Lee Pharmaceuticals, USA5762017-10-312024-05-14

Conditions studied

Diabetes Mellitus (3)  ·  Insulin Resistance (3)  ·  Diabetes Mellitus, Type 1 (2)  ·  Diabetes Mellitus, Type 2 (1)

Sponsors

Gan and Lee Pharmaceuticals, USA (3)

Countries

United States (3)  ·  Czechia (2)  ·  Germany (2)  ·  Hungary (2)  ·  Poland (2)  ·  Spain (2)

Top investigators

Jia Lu, PhD (2)  ·  Elena A. Christofides, MD, FACE (1)  ·  Elena A. Christofides, MD,FACE (1)  ·  Jia Lu, MD, PhD (1)

Results publications

PMID 38558508